Juho Vehviläinen

Juho Vehviläinen

Auto-generated profile, based on publicly available information

Juho Vehviläinen

Department of Neurosurgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2017 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
ETEric Thelin
Eric Thelin
DNDavid W Nelson
David W Nelson
JVJuho Vehviläinen
Juho Vehviläinen
HNHarriet Nyström
Harriet Nyström
RKRiku Kivisaari
Riku Kivisaari
RRRaj Rahul
Raj Rahul
Background: Traumatic brain injury (TBI) is a major contributor to morbidity and mortality. Computerized tomography (CT) scanning of the brain is essential for diagnostic screening of intracranial injuries in need of neurosurgical intervention, but may also provide information concerning patient prognosis and enable baseline risk stratification in clinical trials. Novel CT scoring systems have been developed to improve current prognostic models, including the Stockholm and Helsinki CT scores, but so far have not been extensively validated. The primary aim of this study was to evaluate the Stockholm and Helsinki CT scores for predicting functional outcome, in comparison with the Rotterdam CT score and Marshall CT classification. The secondary aims were to assess which individual components of the CT scores best predict outcome and what additional prognostic value the CT scoring systems contribute to a clinical prognostic model. Methods and findings: TBI patients requiring neuro-intensive care and not included in the initial creation of the Stockholm and Helsinki CT scoring systems were retrospectively included from prospectively collected data at the Karolinska University Hospital (n = 720 from 1 January 2005 to 31 December 2014) and Helsinki University Hospital (n = 395 from 1 January 2013 to 31 December 2014), totaling 1,115 patients. The Marshall CT classification and the Rotterdam, Stockholm, and Helsinki CT scores were assessed using the admission CT scans. Known outcome predictors at admission were acquired (age, pupil responsiveness, admission Glasgow Coma Scale, glucose level, and hemoglobin level) and used in univariate, and multivariable, regression models to predict long-term functional outcome (dichotomizations of the Glasgow Outcome Scale [GOS]). In total, 478 patients (43%) had an unfavorable outcome (GOS 1–3). In the combined cohort, overall prognostic performance was more accurate for the Stockholm CT score (Nagelkerke’s pseudo-R2 range 0.24–0.28) and the Helsinki CT score (0.18–0.22) than for the Rotterdam CT score (0.13–0.15) and Marshall CT classification (0.03–0.05). Moreover, the Stockholm and Helsinki CT scores added the most independent prognostic value in the presence of other known clinical outcome predictors in TBI (6% and 4%, respectively). The aggregate traumatic subarachnoid hemorrhage (tSAH) component of the Stockholm CT score was the strongest predictor of unfavorable outcome. The main limitations were the retrospective nature of the study, missing patient information, and the varying follow-up time between the centers. Conclusions: The Stockholm and Helsinki CT scores provide more information on the damage sustained, and give a more accurate outcome prediction, than earlier classification systems. The strong independent predictive value of tSAH may reflect an underrated component of TBI pathophysiology. A change to these newer CT scoring systems may be warranted.

19 March 2019 in IEEE Transactions on Geoscience and Remote Sensing
Verified
Journal Article
Closed access
QLQinghuan Li
Qinghuan Li
RKRichard Kelly
Richard Kelly
Leena LeppänenLeena Leppänen
Leena Leppänen
JVJuho Vehvilainen
Juho Vehvilainen
AKAnna Kontu
Anna Kontu
JPJouni Pulliainen
Jouni Pulliainen
While many microwave studies related to tree emission have been undertaken, a few have considered the effect of phenological change on the emission from coniferous trees. The permittivity of vegetation tissue is known to be influenced by water content, while the water content and phase is sensitive to temperature in particular at temperatures below freezing. In addition to temperature, canopy-intercepted snow might also modify the tree emission and transmissivity in the microwave range. In this paper, a season-long experiment was designed to quantify the effect of snow accumulation and temperature on the observed microwave transmissivity from tree. A ground-based, upward-pointing multifrequency radiometer was used to monitor the microwave emissivity of a single coniferous tree at a site in Northern Finland. Radiometer measurements were combined with measurements of the canopy-intercepted snow cover and tree skin temperature. This paper presents two important findings. First, the tree transmissivity was strongly correlated with tree skin temperature under subzero temperature conditions, but uncorrelated with skin temperature changes above freezing. Second, although the tree transmissivity was slightly affected by the snow accumulation on the tree canopy, the overall influence on tree emission was statistically insignificant in this paper.

11 August 2021 in Acta Neurochirurgica
Verified
Journal Article
Open access
PDF file
JVJuho Vehviläinen
Juho Vehviläinen
MSMarkus B. Skrifvars
Markus B. Skrifvars
MRMatti Reinikainen
Matti Reinikainen
SBStepani Bendel
Stepani Bendel
IMIvan Marinkovic
Ivan Marinkovic
RRRahul Raj
Rahul Raj
Background: Psychiatric sequelae after traumatic brain injury (TBI) are common and may impede recovery. We aimed to assess the occurrence and risk factors of post-injury psychotropic medication use in intensive care unit (ICU)-treated patients with TBI and its association with late mortality.Methods: We conducted a retrospective multi-centre observational study using the Finnish Intensive Care Consortium database. We included adult TBI patients admitted in four university hospital ICUs during 2003–2013 that were alive at 1 year after injury. Patients were followed-up until end of 2016. We obtained data regarding psychotropic medication use through the national drug reimbursement database. We used multivariable logistic regression models to assess the association between TBI severity, treatment-related variables and the odds of psychotropic medication use and its association with late all-cause mortality (more than 1 year after TBI).Results: Of 3061 patients, 2305 (75%) were alive at 1 year. Of these, 400 (17%) became new psychotropic medication users. The most common medication types were antidepressants (61%), antipsychotics (35%) and anxiolytics (26%). A higher Glasgow Coma Scale (GCS) score was associated with lower odds (OR 0.93, 95% CI 0.90–0.96) and a diffuse injury with midline shift was associated with higher odds (OR 3.4, 95% CI 1.3–9.0) of new psychotropic medication use. After adjusting for injury severity, new psychotropic medication use was associated with increased odds of late mortality (OR 1.19, 95% CI 1.19–2.17, median follow-up time 6.4 years).Conclusions: Psychotropic medication use is common in TBI survivors. Higher TBI severity is associated with increased odds of psychotropic medication use. New use of psychotropic medications after TBI was associated with increased odds of late mortality. Our results highlight the need for early identification of potential psychiatric sequelae and psychiatric evaluation in TBI survivors.

1 September 2022 in Acta Neurochirurgica
Verified
Journal Article
Open access
PDF file
JVJuho Vehviläinen
Juho Vehviläinen
MSMarkus Skrifvars
Markus Skrifvars
MRMatti Reinikainen
Matti Reinikainen
SBStepani Bendel
Stepani Bendel
RLRuut Laitio
Ruut Laitio
RRRahul Raj
Rahul Raj
Background: Admission computed tomography (CT) scoring systems can be used to objectively quantify the severity of traumatic brain injury (TBI) and aid in outcome prediction. We aimed to externally validate the NeuroImaging Radiological Interpretation System (NIRIS) and the Helsinki CT score. In addition, we compared the prognostic performance of the NIRIS and the Helsinki CT score to the Marshall CT classification and to a clinical model. Methods: We conducted a retrospective multicenter observational study using the Finnish Intensive Care Consortium database. We included adult TBI patients admitted in four university hospital ICUs during 2003–2013. We analyzed the CT scans using the NIRIS and the Helsinki CT score and compared the results to 6-month mortality as the primary outcome. In addition, we created a clinical model (age, Glasgow Coma Scale score, Simplified Acute Physiology Score II, presence of severe comorbidity) and combined clinical and CT models to see the added predictive impact of radiological data to conventional clinical information. We measured model performance using area under curve (AUC), Nagelkerke’s R2 statistics, and the integrated discrimination improvement (IDI). Results: A total of 3031 patients were included in the analysis. The 6-month mortality was 710 patients (23.4%). Of the CT models, the Helsinki CT displayed best discrimination (AUC 0.73 vs. 0.70 for NIRIS) and explanatory variation (Nagelkerke’s R2 0.20 vs. 0.15). The clinical model displayed an AUC of 0.86 (95% CI 0.84–0.87). All CT models increased the AUC of the clinical model by + 0.01 to 0.87 (95% CI 0.85–0.88) and the IDI by 0.01–0.03. Conclusion: In patients with TBI treated in the ICU, the Helsinki CT score outperformed the NIRIS for 6-month mortality prediction. In isolation, CT models offered only moderate accuracy for outcome prediction and clinical variables outweighing the CT-based predictors in terms of predictive performance.

1 November 2023 in Acta Neurochirurgica
Verified
Journal Article
Open access
PDF file
JVJuho Vehviläinen
Juho Vehviläinen
JVJyri J. Virta
Jyri J. Virta
MSMarkus B. Skrifvars
Markus B. Skrifvars
MRMatti Reinikainen
Matti Reinikainen
SBStepani Bendel
Stepani Bendel
RRRahul Raj
Rahul Raj
Background: Antiplatelet and anticoagulant medication are increasingly common and can increase the risks of morbidity and mortality in traumatic brain injury (TBI) patients. Our study aimed to quantify the association of antiplatelet or anticoagulant use in intensive care unit (ICU)–treated TBI patients with 1-year mortality and head CT findings. Method: We conducted a retrospective, multicenter observational study using the Finnish Intensive Care Consortium database. We included adult TBI patients admitted to four university hospital ICUs during 2003–2013. The patients were followed up until the end of 2016. The national drug reimbursement database provided information on prescribed medication for our study. We used multivariable logistic regression models to assess the association between TBI severity, prescribed antiplatelet and anticoagulant medication, and their association with 1-year mortality. Results: Of 3031 patients, 128 (4%) had antiplatelet and 342 (11%) anticoagulant medication before their TBI. Clopidogrel (2%) and warfarin (9%) were the most common antiplatelets and anticoagulants. Three patients had direct oral anticoagulant (DOAC) medication. The median age was higher among antiplatelet/anticoagulant users than in non-users (70 years vs. 52 years, p < 0.001), and their head CT findings were more severe (median Helsinki CT score 3 vs. 2, p < 0.05). In multivariable analysis, antiplatelets (OR 1.62, 95% CI 1.02–2.58) and anticoagulants (OR 1.43, 95% CI 1.06–1.94) were independently associated with higher odds of 1-year mortality. In a sensitivity analysis including only patients over 70, antiplatelets (OR 2.28, 95% CI 1.16–4.22) and anticoagulants (1.50, 95% CI 0.97–2.32) were associated with an increased risk of 1-year mortality. Conclusions: Both antiplatelet and anticoagulant use before TBI were risk factors in our study for 1-year mortality. Antiplatelet and anticoagulation medication users had a higher radiological intracranial injury burden than non-users defined by the Helsinki CT score. Further investigation on the effect of DOACs on mortality should be done in ICU–treated TBI patients.

11 November 2020 in Acta Neurochirurgica
Verified
Journal Article
Open access
PDF file
JVJuho Vehviläinen
Juho Vehviläinen
TBTuomas Brinck
Tuomas Brinck
MLMatias Lindfors
Matias Lindfors
JNJussi Numminen
Jussi Numminen
JSJari Siironen
Jari Siironen
RRRaj Rahul
Raj Rahul